The Indian clinical trials sector, like many others, has had to navigate a turbulent 2020 as the pandemic forced a shift in traditional approaches to working amid lock-downs, challenges in patient mobility and re-purposing of clinical sites as COVID-19 care centers.
In a wide-ranging interview with Scrip, Dr Sanish Davis, incoming president of the Indian Society for Clinical Research (ISCR) and...






